Data / Research funding / West Nile Virus
West Nile Virus: 73 NIH awards ($78.4M) to 43 organizations
73 NIH awards ($78.4M) in the NIH spending category West Nile Virus, to 43 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
73 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Validating the Flavivirus Envelope Protein as an Antiviral Target | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,735,490 | March 1, 2020 | February 28, 2026 | YANG, PRISCILLA LI-NING | reporter.nih.gov |
| Transmission dynamics and fitness of reemerging St. Louis encephalitis virus in mosquito vectors and West Nile virus naïve and immune avian reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,161,373 | July 22, 2025 | June 30, 2029 | COFFEY, LARK L | reporter.nih.gov |
| Deciphering the Role of Chemokine Receptor CCR5 in Maternal Flavivirus Infections | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,021,038 | September 2, 2025 | August 31, 2029 | LIM, JEAN KYOU | reporter.nih.gov |
| Recombinant West Nile Virus Vaccine Adjuvanted with SLA-LSQ Optimize Formulation of VSA Adjuvant | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $2,997,218 | July 5, 2022 | July 5, 2025 | CLEMENTS, DAVID | reporter.nih.gov |
| A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $2,948,061 | January 21, 2019 | July 31, 2025 | FIKRIG, EROL | reporter.nih.gov |
| West Nile virus control through mosquitocidal avian bloodmeals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,710,198 | September 22, 2020 | August 31, 2026 | FOY, BRIAN DAVID | reporter.nih.gov |
| A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,486,737 | January 21, 2022 | December 31, 2026 | RICE, CHARLES M | reporter.nih.gov |
| Development of Inhibitors Targeting Flavivirus Methyltransferase | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,302,146 | April 7, 2023 | March 31, 2028 | LI, HONGMIN | reporter.nih.gov |
| Develop a candidate subunit vaccine for Powassan Virus and West Nile virus adjuvanted with Alhydroxiquim-II | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $2,258,969 | September 30, 2018 | September 29, 2023 | DAVID, SUNIL | reporter.nih.gov |
| Quasispecies dynamics in arbovirus persistence emergence and fitness | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,197,799 | May 15, 2007 | January 31, 2027 | EBEL, GREGORY DAVID | reporter.nih.gov |
| Probing Functional States and Inhibition of Flaviviral Proteases Using Nanopore Tweezers | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,190,088 | June 10, 2021 | May 31, 2027 | CHEN, MIN | reporter.nih.gov |
| Identification of the initial cells infected by West Nile virus ex vivo and in vivo | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,178,310 | September 21, 2022 | July 31, 2027 | LIM, JEAN KYOU | reporter.nih.gov |
| Task A71: Comprehensive In Vivo Screening of Viral Pathogens of Pandemic Potential | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,055,396 | August 3, 2022 | August 2, 2025 | BOWEN, RICHARD ARNOLD | reporter.nih.gov |
| Systemic Neurotropic virus infection effects on GI Dysmotility | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,043,482 | July 1, 2020 | April 30, 2025 | STAPPENBECK, THADDEUS S | reporter.nih.gov |
| Modeling the influence of temperature on the evolution of vector-virus interactions | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,926,486 | February 3, 2022 | January 31, 2027 | CIOTA, ALEXANDER TIMOTHY | reporter.nih.gov |
| Statistical innovation to integrate sequences and phenotypes for scalable phylodynamic inference | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,862,316 | April 9, 2021 | March 31, 2026 | SUCHARD, MARC A. | reporter.nih.gov |
| Partial maturation in mosquito-borne flaviviruses: developing new approaches to characterize the role of lattice heterogeneity in fusion, infectivity, and antibody neutralization | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,790,590 | January 20, 2022 | December 31, 2026 | METSKAS, LAUREN ANN | reporter.nih.gov |
| Innate Immunity to West Nile Virus | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,763,090 | July 1, 2024 | May 31, 2029 | OBERST, ANDREW ATWELL | reporter.nih.gov |
| Structure and Assembly of Viruses | NIH | National Cancer Institute | 2021 to 2024 | $1,652,074 | June 1, 1975 | November 30, 2025 | HARRISON, STEPHEN COPLAN | reporter.nih.gov |
| A new mechanism of antiviral activity of 2'-5' Oligoadenylate Synthetase 1 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,641,690 | December 20, 2019 | August 31, 2024 | SARKAR, SAUMENDRA N | reporter.nih.gov |
| Hologenomic basis of WNV vector competence in Culex tarsalis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $1,590,193 | September 23, 2019 | August 31, 2025 | RASGON, JASON L | reporter.nih.gov |
| Innate Immune Mechanisms Controlling Flavivirus Neurovirulence | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,580,000 | September 3, 2024 | August 31, 2029 | GALE, MICHAEL | reporter.nih.gov |
| Treating flaviviruses with mRNA-encoded Cas13 | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,562,785 | June 13, 2024 | May 31, 2029 | SANTANGELO, PHILIP J | reporter.nih.gov |
| Host Factors Controlling Neuroinvasive Flavivirus Pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,555,000 | August 5, 2022 | July 31, 2026 | LAZEAR, HELEN | reporter.nih.gov |
| Modeling biotic and environmental drivers of seasonal West Nile virus transmission | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,462,915 | July 15, 2024 | May 31, 2029 | MEUTI, MEGAN ELIZABETH | reporter.nih.gov |
| Defining the Role of West Nile Virus-Host Protein Interactions in Evading Antiviral Immunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,364,184 | July 1, 2019 | June 30, 2025 | RAMAGE, HOLLY | reporter.nih.gov |
| Arbovirus population biology: temperature impacts on selection and collective dynamics | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,331,529 | September 1, 2023 | August 31, 2027 | EBEL, GREGORY DAVID | reporter.nih.gov |
| Investigating the interactions between viral infection, Tau pathology, and neuroinflammation | NIH | National Institute on Aging | 2023 | $1,281,004 | September 1, 2023 | August 31, 2026 | FUNK, KRISTEN EMILY | reporter.nih.gov |
| Gigapixel digital PCR in Giant Unilamellar Vesicles | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $1,240,197 | September 30, 2014 | March 31, 2023 | ABATE, ADAM R. | reporter.nih.gov |
| Defining the functional interface between the ER and flaviviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,227,856 | June 20, 2018 | May 31, 2024 | CHERRY, SARA | reporter.nih.gov |
| Gigapixel Next-Generation-Sequencing: An Ultra-Sensitive Diagnostic for Infections of the CNS | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,221,032 | November 1, 2023 | October 31, 2027 | ABATE, ADAM R. | reporter.nih.gov |
| Genetic basis for host preference in Culex pipiens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,173,775 | July 1, 2019 | June 30, 2025 | FRITZ, MEGAN LINDSAY | reporter.nih.gov |
| High throughput screening of orthosteric inhibitors of flavivirus protease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,113,417 | February 15, 2018 | January 31, 2025 | LI, HONGMIN | reporter.nih.gov |
| The Role of the RIP Kinases in Coordinating Neuroinflammation and Host Defense | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $882,500 | February 1, 2018 | January 31, 2023 | OBERST, ANDREW ATWELL | reporter.nih.gov |
| Mechanisms of viral RNA maturation by co-opting cellular exonucleases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $833,933 | June 1, 2022 | April 30, 2023 | KIEFT, JEFFREY S | reporter.nih.gov |
| TAM Receptors and Virus Infection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $833,577 | August 21, 2012 | April 30, 2022 | LEMKE, GREG E | reporter.nih.gov |
| Immunomodulatory Effects of Heterochiral Biomaterials | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $677,486 | February 20, 2019 | October 31, 2023 | RUDRA, JAI | reporter.nih.gov |
| Host Regulation of Flavivirus Infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $530,385 | June 6, 2025 | May 31, 2030 | GACK, MICHAELA ULRIKE | reporter.nih.gov |
| Defining West Nile virus infection of the lymphatics using single cell techniques | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $500,500 | July 3, 2024 | May 31, 2026 | SUTHAR, MEHUL SHAMAL | reporter.nih.gov |
| Discovery and Development of Oral Small-molecule Direct-acting Antivirals | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $499,825 | September 29, 2025 | September 29, 2026 | SCARNEO, SCOTT | reporter.nih.gov |
| "Survivor" neurons drive persistent inflammation following West Nile virus infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $485,375 | May 18, 2023 | April 30, 2025 | OBERST, ANDREW ATWELL | reporter.nih.gov |
| Multiplex Serodiagnostic Assays for Pathogenic Arboviruses in Brazil | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $468,917 | June 5, 2020 | May 31, 2025 | WANG, WEI-KUNG | reporter.nih.gov |
| In vivo relevance of the Schlafen-mediated innate immune mechanism in flavivirus infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $460,720 | May 22, 2023 | April 30, 2027 | LLANO, MANUEL | reporter.nih.gov |
| Collaborative cross mice as a new model for diverse human outcomes of St. Louis encephalitis virus disease | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $452,342 | July 7, 2023 | June 30, 2025 | COFFEY, LARK L | reporter.nih.gov |
| Three-dimensional human epithelial cultures as a model for evaluation of flavivirus-host interactions driving infection in the skin | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $446,823 | June 2, 2021 | May 31, 2024 | WEISS, SUSAN R | reporter.nih.gov |
| Interferon-mediated control of neuropathogenic Flaviviruses | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $446,310 | February 12, 2019 | January 31, 2025 | HANNERS, NATASHA WYNDHAM | reporter.nih.gov |
| Transmission dynamics and fitness of reemerging St. Louis encephalitis virus | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $441,250 | July 3, 2023 | June 30, 2025 | COFFEY, LARK L | reporter.nih.gov |
| Sex separation through targeting of conserved female-specific lethal genes in disease vector mosquitoes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $435,875 | March 11, 2021 | February 29, 2024 | SCHEEL, MOLLY DUMAN | reporter.nih.gov |
| Determinants of Usutu virus bird-to-mosquito transmission | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $432,521 | May 21, 2021 | April 30, 2025 | DUGGAL, NISHA | reporter.nih.gov |
| Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology | NIH | National Institute on Aging | 2023 to 2024 | $423,500 | May 15, 2023 | February 28, 2026 | RABER, JACOB | reporter.nih.gov |
| Evolution and pathogenesis of Usutu virus, an emerging arbovirus | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $422,676 | August 19, 2021 | July 31, 2024 | DUGGAL, NISHA | reporter.nih.gov |
| Chromosome scale genome assemblies for Culex pipiens mosquitoes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $415,596 | November 16, 2020 | October 31, 2023 | SHARAKHOVA, MARIA | reporter.nih.gov |
| Astrocyte innate immune mechanisms of post-viral cognitive dysfunction | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $393,750 | December 1, 2020 | May 31, 2022 | KLEIN, ROBYN S. | reporter.nih.gov |
| Non-invasive approaches to mosquito-borne pathogen surveillance using excreta | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $352,953 | March 10, 2021 | February 28, 2025 | PRICE, DANA C | reporter.nih.gov |
| Discovery and Development of Broad-spectrum Protease Inhibitors of Flaviviruses of Significant Public Health Threats | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | February 1, 2020 | January 31, 2023 | REMACLE, ALBERT | reporter.nih.gov |
| Wetlands in Argentinaas hubs for exchange and emigration of bird-borne arboviruses | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $267,488 | August 5, 2024 | July 31, 2029 | DIAZ, ADRIAN ADRIAN | reporter.nih.gov |
| CRISPR-Cas9 base editing approaches to discover ubiquitination events promoting flavivirus infection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $245,895 | November 14, 2024 | October 31, 2026 | JOHNSON, JEFFREY R | reporter.nih.gov |
| Neurotropic Viral Infection in CNS Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2021 | $240,793 | August 1, 2019 | May 31, 2024 | FUNK, KRISTEN EMILY | reporter.nih.gov |
| DEC-205+ Dendritic Cells are Effective at Stimulating a Protective T Cell Response Against WNV Encephalitis | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $220,500 | January 10, 2019 | December 31, 2023 | DURRANT, DOUGLAS MATTHEW | reporter.nih.gov |
| Cell-intrinsic role of caspase-1 in regulating antigen-specific CD8+ T cell responses | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $217,388 | June 1, 2020 | May 31, 2023 | SUTHAR, MEHUL SHAMAL | reporter.nih.gov |
| Evaluating the consequences of genotype displacement and geographic bias of West Nile virus in New York State | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $202,702 | January 21, 2020 | December 31, 2022 | CIOTA, ALEXANDER TIMOTHY | reporter.nih.gov |
| The male-determining locus of Culex quinquefasciatus | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $195,345 | June 1, 2020 | May 31, 2024 | TU, ZHIJIAN JAKE | reporter.nih.gov |
| Quality Control of Antibody Responses by the Innate Signaling Adaptor MAVS | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $191,875 | March 1, 2020 | February 28, 2022 | SCHENTEN, DOMINIK | reporter.nih.gov |
| Developing Novel Tools to Study Chemokine Receptor Ccr5 Expression and Function in Mice | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $169,000 | June 1, 2024 | April 30, 2026 | LIM, JEAN KYOU | reporter.nih.gov |
| Identity and Accessibility of Immunostimulatory Viral RNAs During Flavivirus Infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $156,980 | December 1, 2023 | November 30, 2025 | GENOYER, EMMANUELLE | reporter.nih.gov |
| Investigating the Formation and Function of Subgenomic Flavivirus RNAs During Flavivirus Infection of the Mosquito Vector | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $112,730 | September 1, 2023 | August 31, 2026 | SPEAR, ELIZABETH | reporter.nih.gov |
| Mechanisms and impacts of astrocyte inflammasome activation during viral encephalitis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $108,368 | July 1, 2022 | January 1, 2024 | DAVE, VERONICA ANJALI | reporter.nih.gov |
| Transmission dynamics and fitness of reemerging St. Louis encephalitis virus in mosquito vectors and West Nile virus native and immune avian reservoirs | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $87,244 | January 12, 2026 | June 11, 2027 | BUCZEK, JENNY ANN | reporter.nih.gov |
| Host genetic determinants of neuroinvasive flavivirus pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $86,658 | March 1, 2022 | May 19, 2023 | JASPERSE, BRITTANY | reporter.nih.gov |
| Establishment of cryopreservation methods for sustainable maintenance of Culex spp. mosquito colonies | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $72,000 | June 5, 2020 | May 31, 2023 | RUECKERT, CLAUDIA | reporter.nih.gov |
| Elucidating the Proteolytic Determinants of Flavivirus Infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $60,925 | April 1, 2024 | May 5, 2025 | CORLISS, LOCHLAIN | reporter.nih.gov |
| Investigating Complement Component 3a Signaling in Viral Neuroinflammatory Responses. | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $31,970 | September 1, 2021 | August 31, 2022 | KANMOGNE, MARLENE | reporter.nih.gov |
| Novel Innate Immune Adjuvant for Avian Influenza. West Nile Virus, and ZIKA Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $144 | September 30, 2013 | September 30, 2021 | GALE, MICHAEL | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Colorado State University | Fort Collins, CO | 5 | $8.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 4 | $5.6 million | 0 | $0 |
| University of California at Davis | Davis, CA | 3 | $4.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 1 | $3.7 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 3 | $3.6 million | 0 | $0 |
| University of Washington | Seattle, WA | 5 | $3.3 million | 0 | $0 |
| Hawaii Biotech, Inc. | Honolulu, HI | 1 | $3 million | 0 | $0 |
| L2 Diagnostics, LLC | New Haven, CT | 1 | $2.9 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 2 | $2.6 million | 0 | $0 |
| Rockefeller University | New York, NY | 1 | $2.5 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 2 | $2.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 3 | $2.3 million | 0 | $0 |
| Virovax LLC | Lawrence, KS | 1 | $2.3 million | 0 | $0 |
| University of Massachusetts Amherst | Amherst, MA | 1 | $2.2 million | 0 | $0 |
| Wadsworth Center | Menands, NY | 2 | $2.1 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 1 | $1.9 million | 0 | $0 |
| Purdue University | West Lafayette, IN | 1 | $1.8 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 2 | $1.7 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 1 | $1.7 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 1 | $1.6 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 2 | $1.6 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 1 | $1.6 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 1 | $1.6 million | 0 | $0 |
| University of North Carolina at Charlotte | Charlotte, NC | 2 | $1.5 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 4 | $1.5 million | 0 | $0 |
| Ohio State University | Columbus, OH | 1 | $1.5 million | 0 | $0 |
| Thomas Jefferson University | Philadelphia, PA | 1 | $1.4 million | 0 | $0 |
| Washington University | Saint Louis, MO | 4 | $1.2 million | 0 | $0 |
| University of Maryland, College Park | College Park, MD | 1 | $1.2 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 2 | $946,663 | 0 | $0 |
| Salk Institute for Biological Studies | La Jolla, CA | 1 | $833,577 | 0 | $0 |
| Eydis Bio, Inc. | Durham, NC | 1 | $499,825 | 0 | $0 |
| University of Hawaii | Honolulu, HI | 1 | $468,917 | 0 | $0 |
| University of Texas at El Paso | El Paso, TX | 1 | $460,720 | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 1 | $446,310 | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 1 | $435,875 | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 1 | $423,500 | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 1 | $352,953 | 0 | $0 |
| Plex Pharmaceuticals, Inc. | San Diego, CA | 1 | $300,000 | 0 | $0 |
| National Council Scientific & Tech Res | Ciudad Aut?noma de Buenos Aires | 1 | $267,488 | 0 | $0 |
| Cal Poly Pomona Foundation, Inc. | Pomona, CA | 1 | $220,500 | 0 | $0 |
| Board of Regents, NSHE, obo University of Nevada, Reno | Reno, NV | 1 | $72,000 | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 1 | $60,925 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 28 | $16,946,062 | 0 | $0 |
| 2024 | 33 | $14,023,661 | 0 | $0 |
| 2023 | 30 | $13,069,406 | 0 | $0 |
| 2022 | 37 | $20,635,598 | 0 | $0 |
| 2021 | 37 | $13,756,530 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 59 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 59 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 59 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.